๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans

Paul Matteis

Stock Analyst at Stifel Nicolaus

(4.60)
# 966
Out of 5,162 analysts
768
Total ratings
46.1%
Success rate
10.3%
Average return

Stocks Rated by Paul Matteis

City Therapeutics
Nov 10, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $16.64
Upside: +104.33%
Mentari Therapeutics
Nov 10, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $15.29
Upside: +96.27%
PepGen
Nov 10, 2026
Reiterated: Buy
Price Target: $12
Current: $3.83
Upside: +213.32%
Acumen Pharmaceuticals
Nov 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.1944
Upside: -
Neumora Therapeutics
Nov 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.3668
Upside: -
Vistagen Therapeutics
Nov 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.1995
Upside: -
COMPASS Pathways
Nov 4, 2026
Reiterated: Buy
Price Target: $21
Current: $8.12
Upside: +158.62%
BioMarin Pharmaceutical
Nov 3, 2026
Reiterated: Hold
Price Target: $70 → $66
Current: $61.43
Upside: +7.44%
Seaport Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: $30
Current: $18.31
Upside: +63.84%
Vertex Pharmaceuticals
Nov 3, 2026
Reiterated: Hold
Price Target: $563
Current: $536.45
Upside: +4.95%
Reiterated: Buy
Price Target: $25
Current: $7.52
Upside: +232.45%
Downgraded: Hold
Price Target: $318 → $225
Current: $149.40
Upside: +50.60%
Reiterated: Buy
Price Target: $242 → $286
Current: $251.41
Upside: +13.76%
Reiterated: Buy
Price Target: $53
Current: $40.06
Upside: +32.30%
Reiterated: Buy
Price Target: $28
Current: $9.24
Upside: +203.03%
Reiterated: Buy
Price Target: $46
Current: $23.14
Upside: +98.79%
Reiterated: Buy
Price Target: $63
Current: $46.85
Upside: +34.47%
Reiterated: Buy
Price Target: $17
Current: $2.95
Upside: +476.27%
Reiterated: Buy
Price Target: $37
Current: $15.87
Upside: +133.14%
Reiterated: Buy
Price Target: n/a
Current: $20.30
Upside: -
Reiterated: Buy
Price Target: n/a
Current: $37.75
Upside: -
Reiterated: Buy
Price Target: $56
Current: $23.40
Upside: +139.32%
Reiterated: Buy
Price Target: $60 → $67
Current: $29.12
Upside: +130.08%
Reiterated: Hold
Price Target: $7
Current: $2.97
Upside: +135.69%
Initiated Coverage: Buy
Price Target: $43
Current: $33.27
Upside: +29.25%
Reiterated: Buy
Price Target: $41
Current: $18.40
Upside: +122.83%
Reiterated: Buy
Price Target: $32 → $38
Current: $18.25
Upside: +108.22%
Reiterated: Hold
Price Target: $25
Current: $17.83
Upside: +40.21%
Reiterated: Hold
Price Target: $86 → $68
Current: $27.39
Upside: +148.27%
Reiterated: Buy
Price Target: $188 → $215
Current: $162.86
Upside: +32.02%
Reiterated: Buy
Price Target: $133
Current: $119.04
Upside: +11.73%
Reiterated: Buy
Price Target: $28 → $36
Current: $6.65
Upside: +441.35%
Reiterated: Buy
Price Target: $33
Current: $25.91
Upside: +27.36%
Rated: Hold
Price Target: n/a
Current: $2.57
Upside: -
Rated: Hold
Price Target: n/a
Current: $2.65
Upside: n/a
Reiterated: Buy
Price Target: $5
Current: $9.30
Upside: n/a
Reiterated: Hold
Price Target: $3
Current: $2.77
Upside: n/a
Downgraded: Hold
Price Target: $11 → $20
Current: $77.98
Upside: n/a
Initiated Coverage: Buy
Price Target: $18
Current: $0.00001
Upside: n/a
Reiterated: Buy
Price Target: $14 → $20
Current: $0.0001
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $2.10
Upside: n/a
Reiterated: Buy
Price Target: n/a
Current: $1.05
Upside: n/a
Reiterated: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Reiterated: Hold
Price Target: $14 → $7
Current: $0.3093
Upside: n/a